<div class="container">
    <div class="row">
        <div id="speaker-detail" class="col-lg-6 col-lg-offset-3">
            <div class="row">
                <button title="Close (Esc)" type="button" class="mfp-close">×</button>
                <div class="col-md-4 col-lg-4">
                    <img class="img-responsive" src="img/speaker_501.jpg" alt="" />
                    <br />
                </div>
                <div class="col-md-8 col-lg-8">
                    <h2>Jenny Hsiung 熊婉真 M.S., MBA</h2>
                    <h3>Executive Assistant to President(總經理特助),<br>Taiwan Liposome Company (TLC) 台灣微脂體</h3>
                    <p>Jenny joined TLC in September 2014 as a management trainee. She works closely with the President and senior managers, and is involved in special projects such as construction planning for a GMP plant and optimization of organizational structure for expansion. Prior to TLC, Jenny spent five years in the Process Research & Development group at Genentech. She started out in a rotation program through cell culture, purification, formulation, and analytical development of monoclonal antibodies, and later took on a bigger role in Drug Product processing and tech transfer activities. </p>
                    <p>She received her M.B.A. from Harvard Business School in 2014 and master’s and bachelor’s degrees in Bioengineering from University of California, San Diego.</p>
                </div>
                <div>
                    <p><a href="http://www.tlcbio.com/zh-tw/" target="new">Taiwan Liposome Company (TLC) 台灣微脂體</a></p>
                    <p>Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies. Our strengths lie in lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs for better efficacy and lower toxicity, and thus prolong the product lifecycle of branded drugs.</p>
                    <p>TLC strives to become a global leading biopharmaceutical company, to contribute more towards making a difference in the healthcare industry and make Taiwan biotechnology industry visible in the global arena. Its headquarters is located in Taipei and subsidiaries in the US, the Netherlands, China, Australia, and Japan.
                    </p>
                </div>
            </div>
        </div>
    </div>